A61K9/0087 - CPC Classification Index

ClassID:

20048 ⎘

A61K9/0087 - CPC Classification

Classification description:

Medicinal preparations characterised by special physical form Galenical forms not covered by -

Sub-classes:

A61K9/009 » {Sachets, pouches characterised by the material or function of the envelope } 297
A61K9/0092 » {Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules, nanotubes } 444
A61K9/0095 » {Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches } 3,2K
A61K9/0097 » {Micromachined devices; Microelectromechanical systems [MEMS]; Devices obtained by lithographic treatment of silicon; Devices comprising chips } 281

Recent Application in this class:

20250295671

2025-09-25

Hazardous Agent Injection System

20250295586

2025-09-25

DEFORMABLE NANO-SCALE VEHICLES (DNVS) FOR TRANS-BLOOD BRAIN BARRIER, TRANS-MUCOSAL, AND TRANSDERMAL DRUG DELIVERY

20250127794

2025-04-24

THERAPEUTIC THIAZINE DYE COMPOSITIONS AND METHODS OF USE

20250107927

2025-04-03

Self-Retaining Implantable Drug Delivery Device

20250082828

2025-03-13

MEDICAL DEVICES AND IMPLEMENTS WITH LIQUID-IMPREGNATED SURFACES

20240261269

2024-08-08

COMPOSITION COMPRISING COMBINATION OF RAPAMYCIN AND METFORMIN AND USE THEREOF FOR TREATING NEURODEGENERATIVE DISEASES

20240156739

2024-05-16

SOLID DOSAGE FORM PRODUCTION

20240148657

2024-05-09

SOLID DOSAGE FORM PRODUCTION

20240016985

2024-01-18

Medical devices and implements with liquid-impregnated surfaces

#10

20230104341

2023-04-06

Hazardous Agent Injection System

#11

20220395435

2022-12-15

Fibrous Product For Medicinal, Cosmetic or Dermatologic Use

#12

20220168317

2022-06-02

Therapeutic Thiazine Dye Compositions and Methods of Use

#13

20220126001

2022-04-28

Medical devices and implements with liquid-impregnated surfaces

#14

20210361630

2021-11-25

Composition comprising combination of rapamycin and metformin and use thereof for treating neoplastic diseases

#15

20210283301

2021-09-16

BONE GRAFT SUBSTITUTE AND METHODS FOR MANUFACTURING SAME

#16

20210236689

2021-08-05

BONE GRAFT SUBSTITUTE

#17

20210187122

2021-06-24

MESSENGER RNA THERAPY FOR THE TREATMENT OF FRIEDREICH'S ATAXIA

#18

20200345703

2020-11-05

Composition comprising combination of rapamycin and an activator of AMP kinase and use thereof for treating diseases

#19

20200297757

2020-09-24

SOLUTION OF CARBON MONOXIDE FOR THE TREATMENT OF DISEASE, INCLUDING SICKLE CELL DISEASE

#20

20200289651

2020-09-17

SUSTAINED-RELEASE DRUG CARRIER COMPOSITION

#21

20200268882

2020-08-27

Treatment of autism spectrum disorder and associated symptoms

#22

20200268554

2020-08-27

Self-retaining implantable drug delivery device

#23

20200247978

2020-08-06

Cellulose composition

#24

20200163975

2020-05-28

Hazardous agent injection system

#25

20190351054

2019-11-21

Treatment of autism spectrum disorder and associated symptoms

#26

20190125681

2019-05-02

Solid dosage form production

#27

20190070298

2019-03-07

Sustained-release drug carrier composition

#28

20190029927

2019-01-31

Gas-containing base material and manufacturing method therefor

#29

20190022086

2019-01-24

CONTROLLED RELEASE HYDROCODONE FORMULATIONS

#30

20190000815

2019-01-03

Composition comprising combination of rapamycin and an activator of AMP kinase and use thereof for treating diseases

#31

20180369413

2018-12-27

Messenger RNA therapy for the treatment of Friedreich's ataxia

#32

20180318216

2018-11-08

DEFORMABLE NANO-SCALE VEHICLES (DNVS) FOR TRANS-BLOOD BRAIN BARRIER, TRANS-MUCOSAL, AND TRANSDERMAL DRUG DELIVERY

#33

20180303872

2018-10-25

Solution of carbon monoxide for the treatment of disease, including sickle cell disease

#34

20180296514

2018-10-18

NOVEL FORMULATION OF DICLOFENAC

#35

20180153864

2018-06-07

Composition comprising combination of rapamycin and an activator of AMP kinase and use thereof for treating diseases

#36

20180050133

2018-02-22

Medical devices and implements with liquid-impregnated surfaces

#37

20180015036

2018-01-18

Substance-encapsulating vesicle and process for producing the same

#38

20170361021

2017-12-21

Hazardous agent injection system

#39

20170325477

2017-11-16

Yogurt Premix for Canines

#40

20170209367

2017-07-27

Microneedle device having a peptide therapeutic agent and an amino acid and methods of making and using the same

#41

20170151203

2017-06-01

Infant nutrition for improving fatty acid composition of brain membranes

#42

20170143682

2017-05-25

Composition comprising combination of rapamycin and an activator of AMP kinase and use thereof for treating diseases

#43

20170136080

2017-05-18

NOVEL METHOD FOR THE TOPICAL APPLICATION OF VETERINARY AGENTS

#44

20170136006

2017-05-18

Methods of manufacturing oral dosage forms

#45

20170049698

2017-02-23

NATURAL SUPPLEMENT

#46

20170043093

2017-02-16

Hazardous agent injection system

#47

20170042861

2017-02-16

Sublingual ondansetron spray

#48

20160354470

2016-12-08

Sustained-release drug carrier composition

#49

20160324872

2016-11-10

IMPREGNATED DRESSINGS FOR TREATING DERMATOLOGICAL DISORDERS

#50

20160228429

2016-08-11

Controlled release hydrocodone formulations

#51

20160213732

2016-07-28

PILLOW USING ACORUS GRAMINEUS AND METHOD FOR MANUFACTURING SAME

#52

20160042149

2016-02-11

Method of making a pharmacy compounding system

#53

20160038376

2016-02-11

Cartridge-based pharmacy compounding system

#54

20160030146

2016-02-04

Vaccine delivery devices

#55

20160008279

2016-01-14

COMPOSITIONS AND METHODS FOR TREATING DIGESTIVE DISORDERS

#56

20160008273

2016-01-14

Device and method for treating neuropathy

#57

20150374833

2015-12-31

Polypeptide hydrogel and method for producing same

#58

20150352211

2015-12-10

Implants for administering substances and methods of producing implants

#59

20150335789

2015-11-26

Multicomponent and biocompatible nanocomposite materials, methods of synthesizing same and applications of same

#60

20150306190

2015-10-29

Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions

#61

20150224052

2015-08-13

Process for manufacturing chewable dosage forms for drug delivery and products thereof

#62

20150216810

2015-08-06

Controlled release hydrocodone formulations

#63

20150216809

2015-08-06

Controlled release hydrocodone formulations

#64

20150157573

2015-06-11

Formulation of diclofenac

#65

20150150824

2015-06-04

Formulation of diclofenac

#66

20150119799

2015-04-30

Hazardous agent injection system

#67

20150098906

2015-04-09

MEDICINALLY MARKED ROLLING PAPERS

#68

20150050340

2015-02-19

Sustained-release drug carrier composition

#69

20140377348

2014-12-25

Controlled release hydrocodone formulations

#70

20140377313

2014-12-25

Formulation for providing an enteric coating material

#71

20140348911

2014-11-27

SPRAY FORMULATION OF MESENCHYMAL STEM CELLS FOR THE TREATMENT OF CHRONIC WOUNDS

#72

20140343499

2014-11-20

Microneedle device including a peptide therapeutic agent and an amino acid and methods of making and using the same

#73

20140330198

2014-11-06

Microneedle device having a peptide therapeutic agent and an amino acid, methods of making and using the same

#74

20140271840

2014-09-18

Controlled release hydrocodone formulations

#75

20140271473

2014-09-18

Encapsulated metal ion nanoclusters

#76

20140248359

2014-09-04

Formulation of diclofenac

#77

20140248319

2014-09-04

Multicomponent and biocompatible nanocomposite materials, methods of synthesizing same and applications of same

#78

20140220121

2014-08-07

Formulation of diclofenac

#79

20140186440

2014-07-03

GASTRIC RETENTIVE EXTENDED-RELEASE DOSAGE FORMS COMPRISING COMBINATIONS OF A NON-OPIOID ANALGESIC AND AN OPIOID ANALGESIC

#80

20140161879

2014-06-12

TREATING PAIN IN PATIENTS WITH HEPATIC IMPAIRMENT

#81

20140148495

2014-05-29

MONOLITHIC DRUG DELIVERY SYSTEM

#82

20140135303

2014-05-15

Hazardous agent injection system

#83

20140112981

2014-04-24

Controlled release hydrocodone formulations

#84

20140099376

2014-04-10

Sequestered antagonist formulations

#85

20140093546

2014-04-03

Methods of producing porous resorbable implants

#86

20140024629

2014-01-23

Compositions and methods for the treatment of skin diseases

#87

20140011876

2014-01-09

Composition and method for treatment of diabetes

#88

20130337027

2013-12-19

Medical Devices and Implements with Liquid-Impregnated Surfaces

#89

20130331348

2013-12-12

Process for manufacturing chewable dosage forms for drug delivery and products thereof

#90

20130309279

2013-11-21

Solution of carbon monoxide for the treatment of disease, including sickle cell disease

#91

20130302396

2013-11-14

Co-delivery of stimulatory and inhibitory factors to create temporally stable and spatially restricted zones

#92

20130302253

2013-11-14

CARRIERS FOR THE LOCAL RELEASE OF HYDROPHILIC PRODRUGS

#93

20130295147

2013-11-07

Methods of using gas-filled microvesicles covalently bound to an antigen

#94

20130280316

2013-10-24

Biodegradable non-ophthalmic implants and related methods

#95

20130267608

2013-10-10

Solid, edible, chewable laxative composition

#96

20130266518

2013-10-10

Methods and Compositions for Using Bleomycin-Derivatized Microbubbles

#97

20130251812

2013-09-26

SEQUESTERED ANTAGONIST FORMULATIONS

#98

20130244987

2013-09-19

Compositions and methods for the treatment of skin diseases

#99

20130243841

2013-09-19

CONCENTRATION OF VACCINE ANTIGENS WITH LYOPHILIZATION

#100

20130243825

2013-09-19

Compositions and methods for the treatment of skin diseases

#101

20130216616

2013-08-22

CUSTOMIZED POLYPILLS HAVING HIGH DRUG LOADS

#102

20130209569

2013-08-15

Formulation of diclofenac

#103

20130202711

2013-08-08

Substance-encapsulating vesicle and process for producing the same

#104

20130202669

2013-08-08

Albumin fibers and fabrics and methods of generating and using same

#105

20130197098

2013-08-01

Composition in form of a gel for the virucidal disinfection of mammalian skin

#106

20130195955

2013-08-01

Implants Containing BMP-7

#107

20130177647

2013-07-11

Methods for manipulating satiety

#108

20130177542

2013-07-11

Osteoporosis Treatment Means and Method

#109

20130149377

2013-06-13

Custom-pill compounding system with filler-free capability

#110

20130129816

2013-05-23

Therapeutic composition with enhanced endothelium targeting

#111

20130101521

2013-04-25

METHODS DEVICES AND SYSTEMS OF PREPARING TARGETED MICROBUBBLE SHELLS

#112

20130095150

2013-04-18

Stabilized active compound

#113

20130071470

2013-03-21

Fenugreek seed extract to lower blood cholesterol

#114

20130071447

2013-03-21

Methods for producing ECM-based biomaterials

#115

20130071446

2013-03-21

Infant nutrition for improving fatty acid composition of brain membranes

#116

20130064965

2013-03-14

Methods of producing mesoporous drug delivery implants

#117

20130064863

2013-03-14

Multicomponent and biocompatible nanocomposite materials, methods of synthesizing same and applications of same

#118

20130030367

2013-01-31

Hazardous agent injection system

#119

20120321713

2012-12-20

Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic

#120

20120263790

2012-10-18

Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions

#121

20120157965

2012-06-21

Hazardous agent injection system

#122

20120141574

2012-06-07

Process for manufacturing chewable dosage forms for drug delivery and products thereof

#123

20120136022

2012-05-31

Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic

#124

20120135047

2012-05-31

Formulation of diclofenac

#125

20110293530

2011-12-01

Methods and Compositions for Using Bleomycin-Derivatized Microbubbles

#126

20110262532

2011-10-27

Controlled release hydrocodone formulations

#127

20110230411

2011-09-22

Albumin fibers and fabrics and methods of generating and using same

#128

20110223234

2011-09-15

Process for manufacturing chewable dosage forms for drug delivery and products thereof

#129

20110217354

2011-09-08

Mesoporous implants for administering substances and methods of producing implants

#130

20110217353

2011-09-08

Mesoporous implants for administering substances and methods of producing implants

#131

20110182967

2011-07-28

Implants for administering substances and methods of producing implants

#132

20110150998

2011-06-23

Methods for producing ECM-based biomaterials

#133

20110117197

2011-05-19

Sustained-release drug carrier composition

#134

20110052659

2011-03-03

Implants for administering substances and methods of producing mesoporous implants

#135

20110052657

2011-03-03

Implants for administering substances and methods of producing implants

#136

20100209507

2010-08-19

Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions

#137

20100196474

2010-08-05

Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic

#138

20100003333

2010-01-07

Compositions and methods for treating digestive disorders

#139

20080220055

2008-09-11

Therapeutic composition with enhanced endothelium targeting

#140

20080075759

2008-03-27

Process for manufacturing chewable dosage forms for drug delivery and products thereof

#141

20070178138

2007-08-02

Biodegradable non-opthalmic implants and related methods

#142

20070142291

2007-06-21

Methods for treating irritable bowel syndrome

#143

20070071821

2007-03-29

Formulation for providing an enteric coating material

#144

20060246085

2006-11-02

Methods for manipulating satiety

#145

20060193871

2006-08-31

Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia

#146

20060182801

2006-08-17

Sequestered antagonist formulations

#147

20060147496

2006-07-06

Methods of diagnosing small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions

#148

20050153001

2005-07-14

Fenugreek seed extract to lower blood cholesterol

#149

20050014693

2005-01-20

Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia